Balentine LLC Eli Lilly & CO Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

A detailed history of Balentine LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Balentine LLC holds 1,329 shares of LLY stock, worth $1.06 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,329

Previous 1,245 6.75%

Holding current value

$1.06 Million

Previous $1.13 Million 4.44%

% of portfolio

0.05%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$772.14 - $960.02 $64,859 - $80,641	84 Added 6.75%	1,329 $1.18 Million
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $21.1 Million - $26.5 Million	-29,170 Reduced 95.91%	1,245 $1.13 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $180,621 - $241,645	-305 Reduced 0.99%	30,415 $23.7 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $1.73 Million - $2.04 Million	3,293 Added 12.01%	30,720 $17.9 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $118,673 - $163,608	273 Added 1.01%	27,427 $14.7 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $648,518 - $867,144	1,849 Added 7.31%	27,154 $12.7 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $964,816 - $1.13 Million	-3,106 Reduced 10.93%	25,305 $8.69 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $510,621 - $594,975	1,588 Added 5.92%	28,411 $10.4 Million
Q3 2022 Oct 26, 2022	SELL	$296.48 - $337.87 $4.49 Million - $5.11 Million	-15,132 Reduced 36.07%	26,823 $8.67 Million
Q2 2022 Oct 26, 2022	BUY	$278.73 - $327.27 $9.5 Million - $11.2 Million	34,075 Added 432.42%	41,955 $13.6 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $11.7 Million - $13.7 Million	41,955 New	41,955 $13.6 Million
Q1 2022 Oct 26, 2022	SELL	$234.69 - $291.66 $8 Million - $9.94 Million	-34,075 Reduced 81.22%	7,880 $2.26 Million
Q4 2021 Oct 26, 2022	SELL	$224.85 - $279.04 $8.22 Million - $10.2 Million	-36,548 Reduced 87.11%	5,407 $1.49 Million
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $523,900 - $650,163	-2,330 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $46,536 - $57,269	210 Added 9.91%	2,330 $538,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $57,234 - $74,032	317 Added 17.58%	2,120 $487,000
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $32,535 - $42,118	198 Added 12.34%	1,803 $337,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $11,219 - $14,846	86 Added 5.66%	1,605 $271,000
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $26,319 - $30,443	180 Added 13.44%	1,519 $225,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $6,684 - $8,044	-49 Reduced 3.53%	1,339 $220,000
Q1 2020 May 18, 2020	BUY	$119.05 - $147.35 $43,572 - $53,930	366 Added 35.81%	1,388 $193,000
Q4 2019 Sep 02, 2020	BUY	$106.92 - $132.43 $90,240 - $111,770	844 Added 474.16%	1,022 $134,000
Q3 2019 Nov 15, 2019	BUY	$106.79 - $116.16 $7,688 - $8,363	72 Added 67.92%	178 $20,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $11,743 - $13,707	106 New	106 $12,000
Q1 2019 May 16, 2019	SELL	$111.31 - $131.02 $5,899 - $6,944	-53 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $5,612 - $6,287	53 New	53 $6,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $28,591 - $35,734	-333 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $25,208 - $28,931	333 New	333 $28,000
Q1 2018 May 16, 2018	SELL	$74.21 - $87.6 $223,891 - $264,289	-3,017 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $2,458 - $2,636	-30 Reduced 0.98%	3,017 $255,000
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $234,832 - $260,640	3,047	3,047 $261,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account